Zenas BioPharma, Inc. (ZBIO) stock forecast and price target
Price $28.01 · data as of November 13, 2026
12-month price target
Average target$47.88
Upside / downside+70.9%
Analysts8
ConsensusStrong buy
Low $32.00Average $47.88High $59.00
Gold marker: average target · white marker: today’s price ($28.01)
Analyst ratings
Strong buy 0Buy 7Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-5.62 | −16.3% | $22M |
| Next fiscal year ends December 31, 2027 | $-4.82 | +14.2% | $49M |
| Next quarter ends December 31, 2026 | $-1.31 | +5.8% | $14M |
| Quarter after ends March 31, 2027 | $-1.40 | — | $0 |
Consensus of the analysts covering Zenas BioPharma, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Zenas BioPharma stock price target?
The average 12-month target from 8 analysts is $47.88, 70.9% above the current price of $28.01 Targets range from $32.00 to $59.00.
Is Zenas BioPharma a buy according to analysts?
The consensus rating is “Strong buy” (7 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Zenas BioPharma expected to earn?
Analysts expect EPS of $-5.62 for the fiscal year ending December 31, 2026 and $-4.82 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.